SEC Comment Letter for SRX Global (SRXH) — Apr 21, 2026
SRX Global Inc.
Date: April 21, 2026 · CIK: 0001471727 · Accession: 0000000000-26-004056
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-295049
Letter
Re: SRx Health Solutions, Inc. Registration Statement on Form S-4 Filed on April 14, 2026 File No. 333-295049 Dear Kent Cunningham:
April 21, 2026
Kent Cunningham Chief Executive Officer SRx Health Solutions, Inc. 801 US Highway 1 North Palm Beach, FL 33408
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Sarah Sidwell at 202-551-4733 with any questions.
Sincerely,
Division of
Corporation Finance
Office of
Manufacturing
cc: Louis Lombardo
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> April 21, 2026 Kent Cunningham Chief Executive Officer SRx Health Solutions, Inc. 801 US Highway 1 North Palm Beach, FL 33408 Re: SRx Health Solutions, Inc. Registration Statement on Form S-4 Filed on April 14, 2026 File No. 333-295049 Dear Kent Cunningham: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Sarah Sidwell at 202-551-4733 with any questions. Sincerely, Division of Corporation Finance Office of Manufacturing cc: Louis Lombardo </TEXT> </DOCUMENT>